TC BioPharm (Holdings) plc
DelistedCIK 1872812fmd_1FM6ZXTAFJDJB8HXG3QH7400REManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Dec 31, 2024, 12 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total revenues | 3 | 2 | 2 | 4 | – | – |
| Research and development | 9 | 7 | 6 | 8 | 8 | 5 |
| Total operating expenses | – | – | – | 16 | 14 | 13 |
| Operating income | (10) | (8) | (9) | (12) | (14) | (13) |
| Interest expense | 0 | 0 | 3 | 7 | 0 | – |
| Other non-operating income (expense) | – | – | – | 9 | 7 | (0) |
| Income before taxes | (7) | (7) | (15) | (3) | (7) | (13) |
| Income tax expense | (1) | (1) | (1) | (2) | (1) | (1) |
| Net income from continuing operations | (6) | (5) | (14) | (1) | (6) | (12) |
| Net income | (6) | (5) | (14) | (1) | (6) | (12) |